Substance Abuse and HIV Situation in Malaysia Vicknasingam B Kasinather, PhD Centre for Drug Research Universiti Sains Malaysia.

Slides:



Advertisements
Similar presentations
Combined prevention programs within criminal justice systems – examples from Malaysia A Kamarulzaman, S Kaur, MN Nazar, M Azahari, C Koh, H AlDarraji,
Advertisements

Rolling Out The National Harm Reduction Programme in Malaysia
National AIDS Control Programme 1. National AIDS Control Programme (NACP) launched under Ministry of Health & Family Welfare in 1992 NACP I (1992 – 1999)
“Humanitarian Action” The Saint-Petersburg Charitable Foundation for Medical and Social Programs HAF.
HIV, Drugs & Prisons Photo by Mr. Alessandro Scotti, UNODC Good Will Ambassador Gino Vumbaca.
…at what cost ? …at what cost ?. Ten year review:  Law enforcement at the expense of public health and human rights  Major HIV epidemics among IDU 
Afghanistan’s Present IDUs-HIV/AIDS Situation and future action plan Dr.Saifur-Rehman NACP Director April,11,2007 Islamic Republic of Afghanistan Ministry.
 Insufficient Reliable data in this region  Estimated people living with HIV  The number of new HIV infections in the region increased.
Population-based estimates of prevalence of HIV, HBV and HCV and HIV-related risk behaviors among male injecting drug users in Lagos, Nigeria Waimar Tun.
Behavioral Interventions for HIV Risk Reduction and HIV Prevention: An International Perspective Marek C. Chawarski Yale University School of Medicine.
Harm Reduction.
Annual report 2010: the state of the drugs problem in Europe.
TI for IDUs Sexual IDUBlood Perinatal Unidentified Routes of HIV Transmission SENTINEL SURVEILLANCE 2006 HIV infection in India.
Medical Professionalism and its Relationship to Public Health: Physician Advocacy and State Public Health Policy Thomas Kellogg Program Officer and Advisor.
HIV and AIDS Data Hub for Asia-Pacific Review in slides Sri Lanka Last updated: December 2014.
Thailand is located at the Golden Triangle: Population: 65 millions Current Status of Drug Use and HIV in Thailand Apinun Aramrattana, MD, PhD Faculty.
HIV and AIDS Data Hub for Asia-Pacific HIV and AIDS Data Hub for Asia-Pacific Review in slides China 1.
HIV and AIDS Data Hub for Asia-Pacific 11 HIV and AIDS Data Hub for Asia-Pacific Review in slides Mongolia.
Introduction About HIV/AIDS in Hangzhou Hangzhou Center For Disease Control And Prevention — by Zhao Gang — by Zhao Gang.
Current Substance Abuse Disorders and HIV Situation in Malaysia B. Vicknasingam (1), Singh, D (1), Suppiah, B (1), Schottenfeld, R (2) and Chawarski, M.
Kevin Fenton, MD, PhD National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention August 5, 2008 Update on the US HIV/AIDS Crisis: Current Trends,
HIV and AIDS Data Hub for Asia-Pacific Review in slides Philippines Last updated: November 2014.
Country gallery Malaysia. Basic socio-demographic indicators, Total population (thousands)26,572 Surface area329,847 sq. km Annual population.
National roll-out of database for HIV prevention programmes among civil society organizations in Ukraine Olga Varetska ICF “International HIV/AIDS Alliance.
Paradoxes and Problems in Preventing HIV Infection among Injecting Drug Users and Their Sexual Partners in Eastern Europe and Asia Don C. Des Jarlais,
HIV and AIDS Data Hub for Asia-Pacific Review in slides Malaysia.
HIV and AIDS Data Hub for Asia-Pacific Review in slides Malaysia Last updated: July 2015.
Review in slides Indonesia
HIV and AIDS Data Hub for Asia-Pacific Review in slides Timor-Leste Last updated: December 2014.
Project RAS/H13 “Prevention of transmission of HIV among drug users in SAARC Countries” Lubna Mohamed Zahir Hussain Chairperson of National Drug Agency.
Knowing your Epidemic: Designing Better Interventions in Prisons Deputy Commissioner Mary C. Chepkonga Kenya Prisons Service International AIDS Conference.
HIV and AIDS Data Hub for Asia-Pacific Review in slides India.
By Fred Kigozi M.D WPA Zone 14 Representative/ President Uganda Psychiatric Association, Director Butabika Hospital or
Jennifer R. Havens, PhD, MPH Associate Professor
HIV and AIDS Data Hub for Asia-Pacific Review in slides Myanmar.
HIV and AIDS Data Hub for Asia-Pacific 11 HIV and AIDS Data Hub for Asia-Pacific Review in slides Cambodia.
India Last updated: January 2016.
Delivery Systems for Substance Abuse Treatment Country Presentation - Slovakia Lubomir Okruhlica, M.D., Ph.D. Institute on Drug Dependencies, CTDD Bratislava.
HIV and AIDS Data Hub for Asia-Pacific Review in slides Lao PDR Last updated: July 2015.
00002-E-1 – 1 December 2001 Global summary of the HIV/AIDS epidemic, December 2001 Number of people living with HIV/AIDS Total40 million Adults37.2 million.
HIV and AIDS Data Hub for Asia-Pacific Review in slides Timor-Leste Last updated: January 2016.
00002-E-1 – 1 December 2002 Global summary of the HIV/AIDS epidemic, December 2002 Number of people living with HIV/AIDS Total42 million Adults38.6 million.
1 Scaling-up ARV Therapy in Vietnam HAIVN Harvard Medical School AIDS Initiative in Vietnam.
HIV and AIDS Data Hub for Asia-Pacific Review in slides Pakistan Last updated: January 2016.
HIV and AIDS Data Hub for Asia-Pacific HIV and AIDS Data Hub for Asia-Pacific Review in slides Thailand.
HIV and AIDS Data Hub for Asia-Pacific Review in slides Myanmar Last Update: June 2015.
HIV and AIDS Data Hub for Asia-Pacific Review in slides Timor-Leste.
Main achievements and further developments 2006 and beyond: Overcoming HIV/AIDS epidemic in Ukraine (programme (programme supported by the Global Fund)
HIV and AIDS Data Hub for Asia-Pacific Review in slides Sri Lanka.
HIV and AIDS Data Hub for Asia-Pacific Review in slides Myanmar Last Update: April 2016.
HIV and AIDS Data Hub for Asia-Pacific Review in slides Pakistan.
ARV Treatment Scale Up: Progress in Ukraine Andriy Klepikov Executive Director, International HIV/AIDS Alliance in Ukraine ARV Treatment Scale Up: Progress.
HIV and AIDS Data Hub for Asia-Pacific Review in slides Pakistan Last updated: November 2014.
HIV and AIDS Data Hub for Asia-Pacific Review in slides Sri Lanka Last updated: April 2016.
HIV and AIDS Data Hub for Asia-Pacific Review in slides Japan.
HIV Epidemic in Malaysia. HIV BY AGE GROUPS - MALAYSIA.
Thematic Priorities for ATF Applications Presentation by Secretariat of Council for the AIDS Trust Fund in Briefing Session on 27 July
VOTER STATISTICS 2010 MCCBCHST - NOVEMBER 2011.
Timor-Leste Last updated: January 2016.
Effective HIV & SRH Responses Among Sex Workers and other Key Populations Module 1: National Data.
Mongolia Last updated: April 2016.
Islam & Harm Reduction Adeeba Kamarulzaman
Review in slides Malaysia.
Pakistan Last updated: July 2015.
Malaysia: Needle Syringe and Exchange Program (NSEP)
Myanmar Last Update: September 2016.
China 2010 UNGASS Country Progress Report
Myanmar Last Update: November 2014.
Collaborative TB/HIV activities in European Region
Malaysia Last updated: August 2018.
Presentation transcript:

Substance Abuse and HIV Situation in Malaysia Vicknasingam B Kasinather, PhD Centre for Drug Research Universiti Sains Malaysia

Population: 28 million GDP per capita: $14,275 Industrialized market economy Federal constitutional monarchy Islam is the largest and official religion (61%) Major heroin abuse problem since the 1970s Proximity to Golden Triangle

Drug abuse policies in Malaysia Before 2001, primarily supply-side policies and measures – Oversight by the Internal Security Ministry and the National Anti-Drug Agency Criminalization of drug possession and use, drug testing (e.g., road blocks, areas of high concentration of drug users, workplaces, entertainment venues) and detention of suspected drug users – Drug use, testing positive for drugs, possession of drugs or drug paraphernalia, seeking medical help for drug use problems results in registration in the national database of drug users Many registrants remanded to 2 year detention in rehabilitation centers – Severe criminal penalties Possession of 15 grams (1/2 ounce) of heroin or 200 grams (seven ounces) of marijuana classified by the law as trafficking in drugs Mandatory death sentence for possession of 30 grams of heroin

Number of drug users detected and placed under supervision by the government (2012) No.STATESEK. 6(1)aSEK. 6(1)bSEK. 8(3)aSEK. 8(1)bSEK.9(2)aSEK.9(2)bSEK.38B(1) Prison SEK.38B(2) Fine TOTAL 1.PERLIS KEDAH1,3432, ,914 3.PULAU PINANG7782, ,9381,3116,897 4.PERAK1,5893, ,1776,475 5.SELANGOR1,1032, ,7425,980 6.WPKL ,548 7.NEG SEMBILAN4421, ,464 8.MELAKA ,800 9.JOHOR6241, ,7084, PAHANG8171, ,5713, TERENGGANU ,0404, KELANTAN ,0605, SARAWAK ,049 14SABAH ,512 TOTAL 8,70118, ,17218,26252,925 * Source: Detection and Supervision Unit National Anti Drugs Agency

Recent changes, Malaysia In response to the continuing problems with heroin dependence and the emerging epidemic of HIV/AIDS resulting from injection drug use, Malaysia introduced opiate agonist maintenance treatments (OMT) - Buprenorphine approved in 2002 Currently, approximately 380 general medical practice offices offer agonist maintenance treatments for ~10,000 patients - Methadone approved in 2003 Currently, there are 27,756 active patients in 333 government run MMT centres – Naltrexone registered ?

Recent changes, Malaysia (cont’d) Previously existing programs/measures were retained with plans for slow, gradual elimination or restructuring – Currently, 21 government drug rehabilitation centers are still open (1 center for females) with the total of 5,102 residents/inmates undergoing rehabilitation in 2012 – 42 Cure and Care Service Centres in Malaysia – 1,836 residential and 176,929 non-residential inmates/patients in 2012 – MMT programs were also introduced to prisons beginning with 1 prison in 2008 expanded to 18 MMTs in prisons by 2011

Recent changes, Malaysia (cont’d) NSEP started in 2006 and has reached out to 34,244 IDUs with an average distribution of needle/syringe sets about 116 per IDU in a year (2011) However, the proportions of clients being referred to VCT and MMT are low – ~10% NSEP clients are referred for VCT – ~4% referred and entered MMT Source: Malaysia 2012, Global AIDS Response, Country Progress Report

Overview of the HIV epidemic in Malaysia 2011 IndicatorNumber/ percentage Cumulative no. of reported HIV infections since first detection in ,841 Cumulative no. of reported AIDS since ,686 Cumulative no. of reported deaths related to HIV/AIDS since ,986 Estimated no. PLHIV [EPP 2011]81,000 New HIV infections detected in 20113,479 Notification rate of HIV (per 100,000) in Women reported with HIV in Cumulative no. of women reported with HIV as of December 20119,494 Children aged below 13 with HIV in Cumulative no. of children under 13 with HIV as of December Estimated no. PLHIV eligible for treatment [EPP 2011]37,306 No. PLHIV receiving ART (surveillance data) as of December ,002 Source: Ministry of Health Malaysia

Percentage of new HIV cases by risk factor Risk Factor Injecting drug use470 (60.4%)3,815 (74.7%)1,348 (38.7%) Sexual transmission41 (5.2%)964 (18.8%)1,931 (32.0%) Heterosexual38 (4.8%)902 (17.6%)1,573 (45.2%) Homosexual3 (0.4%)62 (1.2%)358 (10.3%) Source: Ministry of Health (2011)

Amphetamine Type Stimulants (ATS) Methamphetamine seizures in East and Southeast Asia nearly half of world’s total, UNODC says: ‘Significant increase’ in availability, use, arrests and seizures makes meth top illicit drug threat in region, says UNODC (12 Dec 2012) ATS Seizures in Malaysia (2012) ATS Ecstasy Pills98,751772,421 Ecstasy Powder (kg) Yaba Pills364,909521,384 Syabu (kg)1,

Epidemiological Surveys Between 2006 and 2008 USM and Yale researchers conducted a series of surveys among not-in-treatment injection drug users in three cities in Malaysia (Penang, Kuala Lumpur, and Johor Bharu) – 1 st survey: October - November 2006 – 2 nd survey: June - September 2007 – 3 rd survey: January - March 2008 (wave 1) and October March 2009 (wave 2) A total of 732 IDUs were surveyed – 680 males and 53 females Participants were a convenience sample recruited in neighborhoods with known shooting galleries and needle syringe exchange programs Collected information included demographics, drug use history and current patterns of use, self-reported HIV status, behavioral risks, and urine toxicology screens

Timeline of drug use initiation

ATS abuse and HIV status p<0.001

COATS Studies In collaboration with Yale School of Medicine, USM started a research unit in the Medical school to develop medical treatments for Co-occurring Opioid (heroin or morphine) and amphetamine-type stimulants (ATS) dependence (COATS) and to conduct cognitive/neuropsychological and epidemiological studies of ATS and heroin abusers in Malaysia. We are currently conducting several small pilot studies of medications targeting ATS abuse/dependence in Suboxone maintained, opiate dependent individuals

Future Research Needs 1.Epidemiological studies to better understand the behavioral link between ATS use and HIV 2.Development of improved treatment interventions for diverse populations of drug users, and prevention strategies for high risk individuals (e.g., ATS abusers)

Thank you